ArticleJournal of molecular histology2023

P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC.

João Pedro Nassar-Reis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.